Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study. - Nakamura, Naokazu; Arima, Nobuyoshi; Takakuwa, Teruhito; Yoshioka, Satoshi; Imada, Kazunori; Fukushima, Kentaro; Hotta, Masaaki; Fuchida, Shin-ichi; Kanda, Junya; Uoshima, Nobuhiko; Shimura, Yuji; Tanaka, Hirokazu; et al. (Annals of Hematology, 2024)